AXOGEN AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENTTissue Processing Agreement • January 25th, 2012 • AxoGen, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
Contract Type FiledJanuary 25th, 2012 Company Industry JurisdictionThis Amended and Restated AXOGEN Nerve Tissue Processing Agreement (“Agreement”) consists of this signature page, the attached Terms and Conditions, and the Exhibits marked below. This Agreement authorizes LIFENET HEALTH to process human cadaveric tissue for AXOGEN. The term of this Agreement shall commence on the Effective Date and shall end as provided in the Terms and Conditions. For purposes of this Agreement, the “Effective Date” shall be the last date executed below. This Agreement becomes legally binding upon signature below by authorized representatives of the parties, and supersedes the AXOGEN Nerve Tissue Processing Agreement by and between the parties, dated November 16, 2007 (the “Original Agreement”).
AXOGEN AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENTTissue Processing Agreement • October 6th, 2011 • AxoGen, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
Contract Type FiledOctober 6th, 2011 Company Industry JurisdictionThis Amended and Restated AXOGEN Nerve Tissue Processing Agreement (“Agreement”) consists of this signature page, the attached Terms and Conditions, and the Exhibits marked below. This Agreement authorizes LIFENET HEALTH to process human cadaveric tissue for AXOGEN. The term of this Agreement shall commence on the Effective Date and shall end as provided in the Terms and Conditions. For purposes of this Agreement, the “Effective Date” shall be the last date executed below. This Agreement becomes legally binding upon signature below by authorized representatives of the parties, and supersedes the AXOGEN Nerve Tissue Processing Agreement by and between the parties, dated November 16, 2007 (the “Original Agreement”).
THIRD AMENDMENT TO AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENTTissue Processing Agreement • March 15th, 2012 • AxoGen, Inc. • Electromedical & electrotherapeutic apparatus
Contract Type FiledMarch 15th, 2012 Company IndustryTHIS THIRD AMENDMENT (“Third Amendment”) to the Amended and Restated Nerve Tissue Processing Agreement, dated as of February 27, 2008, as amended on June 27, 2008 (“Amendment”), entered into by and among LifeNet Health (“LifeNet”) and AxoGen Corporation (the “Agreement”), is entered into between the parties on March 12, 2012 (“Third Amendment Effective Date”).
SECOND AMENDMENT TO AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENTTissue Processing Agreement • October 6th, 2011 • AxoGen, Inc. • Electromedical & electrotherapeutic apparatus
Contract Type FiledOctober 6th, 2011 Company IndustryTHIS SECOND AMENDMENT (“Second Amendment”) to the Amended and Restated Nerve Tissue Processing Agreement, dated as of February 27, 2008, as amended on June 27, 2008 (“Amendment”), entered into by and among LifeNet Health (“LifeNet”) and AxoGen Corporation (the “Agreement”), is entered into between the parties on August 9, 2011 (“Effective Date”).